Korsana reports Q3 2026 results, advances KRSA-028 toward the clinicNov 5Quarterly updateKorsana Biosciences, Inc.
Korsana Biosciences completes Cyclerion merger, closes $380 million private placementSep 11M&AKorsana Biosciences, Inc.